๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients

โœ Scribed by E. Riva; C. Scagnolari; K. Monteleone; C. Selvaggi; A. Picardi; C. Mazzarelli; E. Pizzigallo; B. Vincenzi; A. Carducci; S. Antonaci; G. Giannelli; G. Antonelli

Book ID
117947775
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
166 KB
Volume
19
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Interleukin 28B polymorphism predicts pe
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4
โœ Stella De Nicola; Alessio Aghemo; Maria Grazia Rumi; Enrico Galmozzi; Luca Valen ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 499 KB ๐Ÿ‘ 1 views

Single nucleotide polymorphisms (SNPs) near the interleukin 28B (IL28B) region are the strongest baseline predictors of a sustained virologic response (SVR) to peg-interferon (PegIFN) and ribavirin (Rbv) in patients with hepatitis C virus (HCV) genotype 1 infection. Whether this holds true for HCV-4

Ribavirin pharmacokinetics and interleuk
Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4
โœ Antonio D'Avolio; Alessia Ciancio; Marco Siccardi; Lorena Baietto; Marco Simiele ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 209 KB ๐Ÿ‘ 1 views

We read with great interest the recent report by Li et al. 1 analyzing the correlation between the clusters of differentiation 24 (CD24) polymorphism and risk of chronic hepatitis B virus (HBV) infection. In their study, the CD24 P170 T allele (thymidine at position 170) was correlated with a strong